SEC Form 4 · accession 0001127602-17-031436
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terence M Berge
Officer — VP Corp. Treasurer
Period of report
Nov 3, 2017
Accepted (ET)
Nov 7, 2017 · 12:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2017 | M | 2,000 | $16.46 | A | 20,250 | D | |
| Common Stock | Nov 3, 2017 | F | 1,129 | $53.37 | D | 19,121 | D | |
| Common Stock | Nov 3, 2017 | M | 2,500 | $26.69 | A | 21,621 | D | |
| Common Stock | Nov 3, 2017 | F | 1,713 | $53.37 | D | 19,908 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $16.46 | Nov 3, 2017 | M | 2,000 | D | — | Jun 1, 2019 | Common Stock | 2,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $26.69 | Nov 3, 2017 | M | 2,500 | D | — | Jun 1, 2018 | Common Stock | 2,500 | 0 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F2The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.